“Improvement of Risk Assessment in Cutaneous Melanoma (CM) by a Prognostic 31-Gene Expression Profile (31-GEP) Test over AJCC-Based Staging Alone”. SKIN The Journal of Cutaneous Medicine, vol. 2, Dec. 2018, p. S70, https://doi.org/10.25251/skin.2.supp.70.